Contact us

Clinical Advisory Board

Clinical Board Members

Aditi U. JOSHI, MD, MSc

Emergency Medicine Physician, Telehealth and Digital Health Expert, US.

Read more

Dr. Aditi U. Joshi is an experienced Emergency Medicine Physician, Author and Telehealth expert working on improving healthcare and equity through technology. Through a decade of working in Telemedicine and digital health, she has a keen interest in making technology effective for patients, providers, and health care systems. 

LinkedIn profile


Head of the Neuroimmunology Center, S. Gerardo Hospital, Monza, Italy

Read more

Professor Guido Cavaletti is a professor of human anatomy at the School of Medicine and Surgery, vice-rector for research and Head of Experimental Neurology unit at the University of Milano-Bicocca. He also works as senior consultant neurologist and head of the outpatient clinic at the Department of Neurology, S. Gerardo University Hospital. He is currently the Chair of the Toxic Neuropathy Consortium of the Peripheral Nerve Society


LinkedIn profile


Onco-Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY

Read more

Dr. Mario Lacouture is a board-certified dermatologist at Mermorial Sloan Kettering Cancer Center in New York and director of a clinical program in Oncodermatology, first program in the field founded by himself in 2006. He specializes in advancing cancer care and its effect in dermatologic conditions of patients after cancer treatments, such as chemotherapy, radiotherapy, and immunotherapies.


LinkedIn profile


Radiology Oncology, Jefferson University Physician, Philadelphia, PA

Read more

Dr. Adam Dicker is a professor of the Radiation Oncology, Pharmacology, and experimental therapies at Thomas Jefferson University. He serves as co-chair Translational Science Committee for the NCI cooperative group. His research includes the use of “smart needles” for diagnostic and therapeutic applications and he also works in prostate cancer focuses on the “self-seeding” of prostate cells with metastatic properties back to the site of origin, which contributes to disease progression.

LinkedIn profile

Marilyn HUANG, MD

Associate Professor, Division of Gynecologic Oncology, Miami, Fl

Read more

Dr. Marilyn Huang is a experienced research director of Translational Gynecologic Oncology and, researcher at Sylvester Comprehensive Cancer Center and associate professor of The University of Miami. Her research is centered on novel therapeutics and innovative drug combinations for trial programs. She has won multiple industry sponsors to evaluate new treatments in gynecologic malignancies, focused in immunotherapy.

LinkedIn profile

Gregory LIP, MD

Cardio-Oncology Expertise, Liverpool Heart & Chest Hospital, Liverpool, UK

Read more

Professor Gregory Lip, MD is a clinical researcher, Price-Evans chair of Cardiovascular Medicine and director of the Liverpool Centre for Cardiovascular Science, at the University of Liverpool, UK. At Aalborg University in Denmark, he is a well-known Professor and adjunct professor at Yonsei University in Korea.

Karin JORDAN, MD, Pr

Leading Senior Physician Haematology and Oncology, University of Heidelberg, Germany

Read more

Professor Karin Jordan is the leading senior physician of the Department of Hematology and Oncology at the University Hospital in Heidelberg, Germany. She also actively works as Chief Physician in the Ernst von Bergmann Clinic in Potsdam. Germany.

Professor Jordan has served as a board member of MASCC/ESMO Antiemetic Guideline Consensus Panel in 2009 and 2015 as well as a member of the ASCO antiemetic guideline panel. She is the ESMO Faculty coordinator for Supportive & Palliative Care and the ESMO Clinical Practice Guidelines subject editor for the supportive care section. Professor Jordan has authored and co-authored more than 120 publications. Her major area of interest is supportive care with a special focus on antiemetic treatment of chemotherapy-induced nausea and vomiting and side effects of new drugs.

LinkedIn profile


Dean of Multidisciplinary Oncology Institute, Genolier Cancer Centre Switzerland

Read more

Dr. Matti Aapro is presently Dean of the Multidisciplinary Oncology Institut at Genolier. He is also a Board Member of ECCO (European CanCer Organisation) and he serves the International Society for Geriatric Oncology (SIOG) as Executive Board Member. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC). He is a member of the ESMO Faculty and chairs the ESMO 2017 Supportive/Palliative Care track. Dr. Aapro is Editor of Critical Reviews in Oncology/Hematology and the Journal of Geriatric Oncology. He has authored more than 350 publications and his major interests are new drug development, breast cancer, cancer in the elderly, and supportive care.

Profile LinkedIn

Paolo BOSSI, MD, Pr

Associate Professor Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia, Italy

Read more

Dr. Paolo Bossi is a medical oncologist devoted to head and neck cancer treatment. He is particularly dedicated to rare head and neck cancers (paranasal sinus cancer, adnexal cancer, nasopharyngeal cancer, salivary gland cancer). He is currently evaluating the impact of treatment and treatment-induced toxicities in elderly patients. He is greatly committed to supportive care and is studying the impact of the microbioma in the development of treatment-related toxicities. He is also dedicated to non-melanoma skin cancer, with a strong commitment to translational evaluation of the response to new drugs.

Pere Gascón, MD, PhD

Chief of Medical Oncology and Scientific Coordinator, Hospital Clínic, Barcelona, Spain.

Read more

Prof. Gascón holds the position of Director, Division of Medical Oncology and, Scientific Coordinator of the Hematology-Oncology Department, at the Hospital Clinic in Barcelona. He is board-certified in internal medicine and hematology, as well as medical oncology.

From 1985 to 1999, he was the Director of the Division of Hematology-Oncology at UMDNJ-New Jersey Medical School where he graduated with a PhD. He has published more than 200 papers in peer-reviewed journals.

His main clinical interests are in breast and colorectal cancer and in palliative care, in particular bone marrow toxicities.

Back to top
Follow us: subscribe